The Cannigma is conducting a series of consumer experience surveys on cannabis products and participant recruitment for the CHRONIC PAIN segment is now open! 🌱
Here’s how it works:
• Sign up and pass screening
• Receive a (free) 12-week supply of cannabis/CBD products
• Spend 1 minute/day answering questions on your experience
• Get insights into consumption patterns and empower the cannabis community with solid data
This study, which is being carried out by researchers from the University of Michigan in collaboration with the Releaf App, and two cannabis brands, aims to identify product and dosing efficacy trends for pain specific to rheumatoid arthritis, osteoarthritis and fibromyalgia. Registration is open to current California residents.
There are three distinct cannabinoid-based products included in this study, with different combinations of THC, CBD and minor cannabinoids, all in capsule or tablet form. Each product is specifically formulated to be used as medicine.
**They will have more product research studies on anxiety, appetite, sex and pain. Let us know which studies you would be interested in.